Skin melanoma cells produce diverse gelsolin (GSN) isoforms, which play non-redundant roles in cells’ proliferation and motility.

Publication date: Jul 01, 2025

Skin melanoma is a malignant tumor that becomes increasingly difficult to treat when diagnosed late. Previously, we demonstrated that high levels of gelsolin (GSN) correlate with the advanced stages of cutaneous melanoma. GSN can be produced as various isoforms due to alternative splicing and differing start codon positions. To date, no studies have been conducted to determine whether GSN diverse isoforms are produced by melanoma cells in vivo and melanoma cell lines. Therefore, nothing is known about the role of specific GSN isoforms in skin melanoma biology. We applied immunocytochemical staining to melanoma tissue samples to analyze the localization of GSN production within tumor samples. Additionally, we utilized bioinformatics analysis of transcript levels coding for selected GSN isoforms in publicly available gene transcript databases. To investigate the role of these GSN isoforms, we used the melanoma A375 cell line with GSN knockout to restore the production of only one GSN isoform at a time in these cells. We evaluated the modified cells’ ability to migrate, spread, and regulate actin polymerization. We also tested the cells growing on laminin 1, a significant component of the basement membrane, and the melanoma microenvironment. We found that GSN expression produces three GSN isoforms in human melanoma cell lines: two cytosolic (B and C) and one secretory (A). Furthermore, we noted the presence of GSN both intracellularly and extracellularly in melanoma tumor samples, indicating that human melanoma cells produce diverse GSN isoforms in vivo. We discovered that cells producing GSN-A invade more efficiently, while cells producing GSN-C form the longest filipodia and migrate the best in 2D conditions. Both GSN-B and -C decrease the amount of filamentous actin. On the other hand, cells producing GSN-A and -B exhibit a lower proliferation rate. Finally, we observed that tumors formed by the clones expressing individual GSN isoforms do not grow in zebrafish embryos. Overall, we demonstrate that GSN isoforms are produced as a mixture in melanoma cells and are not redundant in their function. Therefore, to support the well-being of melanoma cells, a mixture of GSN isoforms must be produced.

Open Access PDF

Concepts Keywords
Biology Adhesion
Date Cancer
Microenvironment Gelsolin (GSN)
Tumor Isoforms
Zebrafish Motility
Phenotypic heterogeneity
Skin melanoma

Semantics

Type Source Name
disease MESH melanoma
pathway KEGG Melanoma
disease MESH tumor
pathway REACTOME Reproduction
disease MESH noma
pathway KEGG Endocytosis
drug DRUGBANK ATP
drug DRUGBANK Magnesium
drug DRUGBANK Calcium cation
drug DRUGBANK Amino acids
drug DRUGBANK L-Cysteine
drug DRUGBANK Ethionamide
pathway REACTOME Metabolism
disease MESH carcinogenesis
disease MESH lung cancer
disease MESH metastasis
drug DRUGBANK Indoleacetic acid
pathway REACTOME Translation
drug DRUGBANK Honey
drug DRUGBANK Methylergometrine
drug DRUGBANK Hyaluronic acid
drug DRUGBANK Albendazole
drug DRUGBANK Trestolone
pathway REACTOME Digestion
drug DRUGBANK Gelatin
pathway KEGG Focal adhesion
drug DRUGBANK Fluorescein
disease MESH respiratory distress syndrome
disease MESH necrosis
disease MESH septic shock
disease MESH hepatocellular carcinoma
pathway KEGG Hepatocellular carcinoma
drug DRUGBANK Coenzyme M
drug DRUGBANK Sphingosine
drug DRUGBANK Phosphate ion
disease MESH acute lymphocytic leukemia
disease MESH causes
drug DRUGBANK Sodium bicarbonate
pathway REACTOME Release
drug DRUGBANK Topiramate
pathway REACTOME Fertilization
drug DRUGBANK Formaldehyde
drug DRUGBANK Ademetionine
drug DRUGBANK Hydrogen peroxide
drug DRUGBANK Water
drug DRUGBANK Ammonia
drug DRUGBANK Medical air
drug DRUGBANK Puromycin
drug DRUGBANK Gentian violet cation
drug DRUGBANK Acetic acid
drug DRUGBANK L-Isoleucine
drug DRUGBANK Tretamine
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Tricyclazole
drug DRUGBANK Pixantrone
drug DRUGBANK Urea
drug DRUGBANK Tromethamine
drug DRUGBANK Sodium lauryl sulfate
drug DRUGBANK Sucrose
drug DRUGBANK Serine
drug DRUGBANK L-Tyrosine
disease MESH carcinoma
disease MESH pancreatic cancer
pathway KEGG Pancreatic cancer
disease MESH colorectal cancer
pathway KEGG Colorectal cancer
disease MESH colon adenocarcinoma
disease MESH subarachnoid hemorrhage
disease MESH Stroke
drug DRUGBANK Aspartame
pathway REACTOME Invadopodia formation
disease MESH goiter
disease MESH papillary thyroid carcinoma
disease MESH tick borne encephalitis
disease MESH Neuroinflammation

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *